|
2471 |
Pembrolizumab
Enthalten in Reactions weekly Bd. 1650, 6.5.2017, Nr. 1, date:5.2017: 226
|
|
|
|
2472 |
Pembrolizumab
Enthalten in Reactions weekly Bd. 1658, 1.7.2017, Nr. 1, date:7.2017: 374
|
|
|
|
2473 |
Pembrolizumab
Enthalten in Reactions weekly Bd. 1658, 1.7.2017, Nr. 1, date:7.2017: 373
|
|
|
|
2474 |
Pembrolizumab
Enthalten in Reactions weekly Bd. 1662, 29.7.2017, Nr. 1, date:7.2017: 293
|
|
|
|
2475 |
Pembrolizumab
Enthalten in Reactions weekly Bd. 1658, 1.7.2017, Nr. 1, date:7.2017: 375
|
|
|
|
2476 |
Pembrolizumab
Enthalten in Reactions weekly Bd. 1629, 26.11.2016, Nr. 1, date:11.2016: 201
|
|
|
|
2477 |
Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists
Enthalten in BioDrugs Bd. 31, 19.9.2017, Nr. 5, date:10.2017: 447-459
|
|
|
|
2478 |
„Perfektion ist nicht der Sinn des Lebens.“
Enthalten in Orthopädie & Rheuma Bd. 20, 20.2.2017, Nr. 1, date:2.2017: 13-14
|
|
|
|
2479 |
Performance of risk assessment tools for predicting osteoporosis in south Indian rural elderly men
Enthalten in Archives of osteoporosis Bd. 12, 5.4.2017, Nr. 1, date:12.2017: 1-5
|
|
|
|
2480 |
Perioperative complications after surgical treatment in degenerative adult de novo scoliosis
Enthalten in BMC musculoskeletal disorders Bd. 19, 10.1.2018, Nr. 1, date:12.2018: 1-11
|
|
Administration
